Literature DB >> 19252764

No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.

Janet W de Beukelaar, Johannes C Milikan, Georges M Verjans, Marieke T de Graaf, Yvette van Norden, Cor H Lamers, Martin J van den Bent, Jacoline E Bromberg, Esther Hulsenboom, Kees Sintnicolaas, Jan W Gratama, Peter A Sillevis Smitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19252764     DOI： 10.1007/s00415-009-0051-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  T cell response to Hu-D peptides in patients with anti-Hu syndrome.

Authors:  A Rousseau; B Benyahia; J Dalmau; F Connan; J-G Guillet; J-Y Delattre; J Choppin
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

2.  Resolution of EBV(+) CNS lymphoma with appearance of CSF EBV-specific T cells.

Authors:  Janet W de Beukelaar; Cornelis van Arkel; Martin J van den Bent; Mars B van't Veer; Gerard J van Doornum; Jan J Cornelissen; Peter A Sillevis Smitt; Jan W Gratama
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

3.  Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice.

Authors:  P A Sillevis Smitt; G T Manley; J B Posner
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

4.  Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.

Authors:  J W Gratama; J W van Esser; C H Lamers; C Tournay; B Löwenberg; R L Bolhuis; J J Cornelissen
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

5.  Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human.

Authors:  Anne Plonquet; Francisco Garcia-Pons; Eric Fernandez; Caramelle Philippe; Jeanine Marquet; Hélène Rouard; Marie Hélène Delfau-Larue; Konstantinos Kosmatopoulos; François Lemonnier; Jean Pierre Farcet; Romain K Gherardi; Pierre Langlade-Demoyen
Journal:  J Neuroimmunol       Date:  2003-09       Impact factor: 3.478

6.  Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome.

Authors:  Masami Tanaka; Yoshie Maruyama; Miho Sugie; Hitoshi Motizuki; Keiko Kamakura; Keiko Tanaka
Journal:  J Neurol Sci       Date:  2002-09-15       Impact factor: 3.181

7.  Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis.

Authors:  W C Jean; J Dalmau; A Ho; J B Posner
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

8.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

9.  Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis.

Authors:  Johannes C M Milikan; Robert W A M Kuijpers; G Seerp Baarsma; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  Exp Eye Res       Date:  2006-03-10       Impact factor: 3.467

10.  No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.

Authors:  Janet W de Beukelaar; Georges M Verjans; Yvette van Norden; Johannes C Milikan; Jaco Kraan; Herbert Hooijkaas; Kees Sintnicolaas; Jan W Gratama; Peter A Sillevis Smitt
Journal:  Cancer Immunol Immunother       Date:  2007-02-14       Impact factor: 6.968
View more
  6 in total

1.  Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.

Authors:  Adriaan H C de Jongste; Marieke T de Graaf; Emanuela Martinuzzi; Patricia D M van den Broek; Jaco Kraan; Cor H J Lamers; Roberto Mallone; Jan W Gratama; Peter A E Sillevis Smitt
Journal:  Neuro Oncol       Date:  2012-05-15       Impact factor: 12.300

Review 2.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401

3.  Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.

Authors:  Mikołaj Piotr Zaborowski; Patrycja Stefens-Stawna; Krystyna Osztynowicz; Tomasz Piorunek; Halina Batura-Gabryel; Agnieszka Dyzmann-Sroka; Wojciech Kozubski; Ewa Nowak-Markwitz; Sławomir Michalak
Journal:  Cancer Immunol Immunother       Date:  2020-11-02       Impact factor: 6.968

Review 4.  Cell-mediated immune responses in paraneoplastic neurological syndromes.

Authors:  Mikolaj Piotr Zaborowski; Slawomir Michalak
Journal:  Clin Dev Immunol       Date:  2013-12-30

Review 5.  Paraneoplastic Diseases of the Central Nervous System.

Authors:  Jonathan Galli; John Greenlee
Journal:  F1000Res       Date:  2020-03-06

Review 6.  Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis.

Authors:  John E Greenlee; Noel G Carlson; Justin R Abbatemarco; Ida Herdlevær; Stacey L Clardy; Christian A Vedeler
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.